Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
AGORACOM NEWS FLASH

BREAKING NEWS!!!

Namaste Announces Signing of MOU With Canopy Growth Corporation

  • MOU with Canopy Growth Corporation  (TSX:WEED), a world-leading diversified cannabis company
  • Represents the execution of Namaste’s strategic objective to actively migrate medical cannabis consumers to a licensed producer
  • Purpose of MOU is to define the intention of Namaste and Canopy to expand their respective market positions by seeking to form multi-point working arrangements and exploring the development of new delivery devices for the consumption of cannabis

Nlogo

Hub On AGORACOM / Read Release

Message: Afrezza sales could be higher than Exubera, says Summer Street

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

Share
New Message
Please login to post a reply